Macugen/Visudyne Concomitant Use Appears Safe – Cmte; QLT Wants Trials
Executive Summary
Concomitant use of Pfizer/Eyetech's Macugen (pegaptanib) with Novartis/QLT's Visudyne (verteporfin) does not pose safety concerns, FDA's Dermatologic & Ophthalmic Drugs Advisory Committee concluded Aug. 27